I've heard from a friend that runs a pharmacy that Biome is his most profitable product and it sits front and centre.
Good sales momentum - organic grown and new products, growing market share locally & overseas, excellent distribution channel and positive free cash flow a reality ... yet de-rate continues. Too may people who got seed still bailing out ... but once this is all out, then we should expect fundamentals to shine through.
Ann: Quarterly Activities & Cashflow Report, page-4
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
68.0¢ |
Change
0.015(2.26%) |
Mkt cap ! $149.0M | |||
| Open | High | Low | Value | Volume |
| 66.5¢ | 69.0¢ | 66.0¢ | $173.2K | 255.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 46226 | 68.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 69.0¢ | 83602 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| BIO (ASX) Chart |